Results 241 to 250 of about 233,688 (312)

Cnidarian toxins: omics approaches and recombinant proteins. [PDF]

J Venom Anim Toxins Incl Trop Dis
Vega-Tamayo JE, Alcantar-Orozco EJ, Mendoza-Ramírez RA, Silva-Díaz LG, Aguilar-Salazar JA, Salvador-Aguilar DH, Rojas-Molina A.   +6 more
europepmc   +1 more source

Comparative effects of second-line oral antidiabetic medications on atrial fibrillation risk in patients with type 2 diabetes: a nationwide retrospective cohort study. [PDF]

Cardiovasc Diabetol
Heo GY, Heo SJ, Ko B, Ko YE, Koh HB, Park CH, Park JT, Han SH, Yoo TH, Kang SW, Han M, Kim HW.   +11 more
europepmc   +1 more source

Co-option of an ancestral peptidase controls developmental patterning in multicellular cyanobacteria. [PDF]

iScience
Xu X, Scholivet A, Champ S, Bergé M, Yeerkenjiang Z, Desjardins J, Denis Y, Douzi B, Byrne D, Talla E, Latifi A.   +10 more
europepmc   +1 more source

The Effect of GLP-1 Receptor Agonists on Epilepsy: No Appetite for Seizures. [PDF]

Epilepsy Curr
Karakis I.
europepmc   +1 more source

CLPB deficiency-associated congenital neutropenia: A rare case report and literature review. [PDF]

Medicine (Baltimore)
Sun Y, Tang M, He J, Hu X, Li M, Tan L.
europepmc   +1 more source

Thyroid Cancer Risk in Patients With Type 2 Diabetes Taking Glucagon-Like Peptide 1 Receptor Agonists. [PDF]

OTO Open
Sciscent BY, Eberly HW, Lorenz FJ, Goldrich D, Goyal N, Goldenberg D.   +5 more
europepmc   +1 more source

SGLT2 Inhibitor Use and Cardiorenal Outcomes in Type 2 Diabetes With Liver Cirrhosis.

JAMA Netw Open
Chung MC, Yu TM, Wu LY, Wu MJ, Shieh JJ, Chung CJ.   +5 more
europepmc   +1 more source